Cruciferous vegetables intake and risk of prostate cancer: A meta-analysis

International Journal of Urology

Volumn 19, Issue 2, 2012, Pages 134-141

  Liu, Ben ^a   Mao, Qiqi ^a   Cao, Min ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cruciferous vegetables; Meta analysis; Prostatic neoplasms

Indexed keywords

ARTICLE; CANCER PREVENTION; CANCER RISK; CRUCIFEROUS VEGETABLE; FOOD INTAKE; GEOGRAPHIC ORIGIN; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; VEGETABLE;

BRASSICACEAE; FOOD HABITS; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK ASSESSMENT; VEGETABLES; WORLD HEALTH;

EID: 84856235306     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02906.x     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127: 2893-917.
2. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J. Clin. 1997; 47: 273-87.
3. Key T. Risk factors for prostate cancer. Cancer Surv. 1995; 23: 63-77.
4. Vainio H, Weiderpass E. Fruit and vegetables in cancer prevention. Nutr. Cancer 2006; 54: 111-42.
5. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004; 134: 3479S-3485S.
6. Kim MK, Park JH. Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Nutrition and health". Cruciferous vegetable intake and the risk of human cancer: epidemiological evidence. Proc. Nutr. Soc. 2009; 68: 103-10.
7. Hsing AW, McLaughlin JK, Schuman LM etal. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990; 50: 6836-40.
8. Jain MG, Hislop GT, Howe GR, Ghadirian P. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr. Cancer 1999; 34: 173-84.
9. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J. Natl. Cancer Inst. 2000; 92: 61-8.
10. Kolonel LN, Hankin JH, Whittemore AS etal. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev. 2000; 9: 795-804.
11. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2003; 12: 1403-9.
12. Joseph MA, Moysich KB, Freudenheim JL etal. Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr. Cancer 2004; 50: 206-13.
13. Stram DO, Hankin JH, Wilkens LR etal. Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States). Cancer Causes Control 2006; 17: 1193-207.
14. Darlington GA, Kreiger N, Lightfoot N, Purdham J, Sass-Kortsak A. Prostate cancer risk and diet, recreational physical activity and cigarette smoking. Chronic Dis. Can. 2007; 27: 145-53.
15. Kirsh VA, Peters U, Mayne ST etal. Prospective study of fruit and vegetable intake and risk of prostate cancer. J. Natl. Cancer Inst. 2007; 99: 1200-9.
16. Takachi R, Inoue M, Sawada N etal. Fruits and vegetables in relation to prostate cancer in Japanese men: the Japan Public Health Center-Based Prospective Study. Nutr. Cancer 2010; 62: 30-9.
17. Villeneuve PJ, Johnson KC, Kreiger N, Mao Y. Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 1999; 10: 355-67.
18. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol. Biomarkers Prev. 1998; 7: 673-80.
19. Key TJ, Allen N, Appleby P etal. Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 2004; 109: 119-24.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959; 22: 719-48.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
23. Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr. Cancer 2002; 42: 1-9.
24. Steinbrecher A, Nimptsch K, Husing A, Rohrmann S, Linseisen J. Dietary glucosinolate intake and risk of prostate cancer in the EPIC-Heidelberg cohort study. Int. J. Cancer 2009; 125: 2179-86.
25. Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res. 2007; 55: 224-36.
26. Powolny AA, Bommareddy A, Hahm ER etal. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J. Natl. Cancer Inst. 2011; 103: 571-84.
27. Wang LG, Liu XM, Chiao JW. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Carcinogenesis 2006; 27: 2124-32.
28. Hwang ES, Lee HJ. Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells. Int. J. Food Sci. Nutr. 2010; 61: 324-36.
29. Gibbs A, Schwartzman J, Deng V, Alumkal J. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Proc. Natl. Acad. Sci. U.S.A. 2009; 106: 16663-8.
30. Singh SV, Warin R, Xiao D etal. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res. 2009; 69: 2117-25.
31. Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int. J. Oncol. 2004; 24: 187-92.
32. Cho HJ, Park SY, Kim EJ, Kim JK, Park JH. 3, 3′-diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model. Mol. Carcinog. 2011; 50: 100-112.
33. Chinnakannu K, Chen D, Li Y etal. Cell cycle-dependent effects of 3, 3′-diindolylmethane on proliferation and apoptosis of prostate cancer cells. J. Cell. Physiol. 2009; 219: 94-9.